Actively Recruiting
Multiomics Biomarkers for Urolithiasis
Led by Chinese University of Hong Kong · Updated on 2024-01-23
1200
Participants Needed
1
Research Sites
292 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective case series study. To compare urine sample of recurrent stone-formers and non-stone former by multiomics approach to identify potential markers for stone recurrence.
CONDITIONS
Official Title
Multiomics Biomarkers for Urolithiasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with history of recurrent urinary stone
- Age greater than or equal to 18 years old
- Have more than 2 episodes of radio-opaque stone disease (bilateral stones counted as two episodes)
- Patients with no history of urinary stone disease
- Age greater than or equal to 18 years old
- No history of urinary calculi by history and imaging
You will not qualify if you...
- Patient refused or unable to provide consent for the study
- Patient with active urinary infection
- Patient with radiolucent stone or infective stone
- Patients with no history of urinary stone disease (for control group)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Shatin, Hong Kong
Actively Recruiting
Research Team
C
Chi Fai NG, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here